Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats

Acta Pharmacologica Sinica

Volumn 33, Issue 12, 2012, Pages 1518-1524

  Yi, En Tong ^a   Liu, Rui Xia ^a   Wen, Yan ^a   Yin, Cheng Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Bile duct ligation; Epatic fibrosis; Telmisartan; The Knodell and Ishak scoring system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE DUCT LIGATION; CONTROLLED STUDY; DRUG TISSUE LEVEL; EXPERIMENTAL RAT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BILE DUCTS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER CIRRHOSIS; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84870843827     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.115     Document Type: Article

References (26)

1. Pereira RM, Dos Santos RA, Teixeira MM, Leite VH, Costa LP, da CostaDias FL, et al. The renin-angiotensin system in a rat model of hepaticfibrosis: evidence for a protective role of angiotensin-(1-7). J Hepatol2007; 46: 674-81
2. Lubel JS, Herath CB, Burrell LM, Angus PW. Liver disease and therenin-angiotensin system: recent discoveries and clinical implications.J Gastroenterol Hepatol 2008; 23: 1327-38
3. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, et al.Chronic liver injury in rats and humans upregulates the novel enzymeangiotensin converting enzyme 2. Gut 2005; 54: 1790-6
4. Castro-Chaves P, Cerqueira R, Pintalhao M, Leite-Moreira AF. Newpathways of the renin-angiotensin system: the role of ACE2 incardiovascular pathophysiology and therapy. Expert Opin Ther Targets2010; 14: 485-96
5. Dejima T, Tamura K, Wakui H, Maeda A, Ohsawa M, Kanaoka T, et al.Prepubertal angiotensin blockade exerts long-term therapeutic effectthrough sustained ATRAP activation in salt-sensitive hypertensive rats.J Hypertens 2011; 29: 1919-29
6. Huang ML, Li X, Meng Y, Xiao B, Ma Q, Ying SS, et al. Upregulationof angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACEinhibitors. Clin Exp Pharmacol Physiol 2010; 37: e1-6
7. Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, et al.Angiotensin-(1-7), an alternative metabolite of the renin-angiotensinsystem, is up-regulated in human liver disease and has antifibroticactivity in the bile-duct-ligated rat. Clin Sci (Lond) 2009; 117:375-86
8. Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, SwartJ, et al. Reduction of advanced liver fibrosis by short-term targeteddelivery of an angiotensin receptor blocker to hepatic stellate cells inrats. Hepatology 2010; 51: 942-52
9. Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, et al.The effect of angiotensin-blocking agents on liver fibrosis in patientswith hepatitis C. Liver Int 2009; 29: 748-53
10. Soler MJ, Ye M, Wysocki J, William J, Lloveras J, Batlle D. Localizationof ACE2 in the renal vasculature: amplification by angiotensin II type1 receptor blockade using telmisartan. Am J Physiol Renal Physiol2009; 296: F398-405
11. Yang L, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA, et al.Attenuated hepatic inflammation and fibrosis in angiotensin type 1areceptor deficient mice. J Hepatol 2005; 43: 317-23
12. Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, etal. Systemic infusion of angiotensin II exacerbates liver fibrosis in bileduct-ligated rats. Hepatology 2005; 41: 1046-55
13. Schuppan D, Gorrell MD, Klein T, Mark M, Afdhal NH. The challengeof developing novel pharmacological therapies for non-alcoholicsteatohepatitis. Liver Int 2010; 30: 795-808
14. Iwai M, Horiuchi M. Devil and angel in the renin-angiotensin system:ACE-angiotensin II-AT1 receptor axis vs ACE2-angiotensin-(1-7)- Masreceptor axis. Hypertens Res 2009; 32: 533-6
15. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibitsgrowth of cardiac myocytes through activation of the mas receptor.Am J Physiol Heart Circ Physiol 2005; 289: H1560-6
16. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD. The role ofangiotensin converting enzyme 2 in the generation of angiotensin1-7 by rat proximal tubules. Am J Physiol Renal Physiol 2005; 288:F353-62
17. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N,et al. Formulation and application of a numerical scoring systemfor assessing histological activity in asymptomatic chronic activehepatitis. Hepatology 1981; 1: 431-5
18. Moriyama T, Aoyama H, Ohnishi S, Imawari M. Protective effects offibronectin in galactosamine-induced liver failure in rats. Hepatology1986; 6: 1334-9
19. Kim MY, Baik SK, Park DH, Jang YO, Suk KT, Yea CJ, et al. Angiotensinreceptor blockers are superior to angiotensin-converting enzymeinhibitors in the suppression of hepatic fibrosis in a bile duct-ligatedrat model. J Gastroenterol 2008; 43: 889-96
20. Karimian G, Mohammadi-Karakani A, Sotoudeh M, Ghazi-KhansariM, Ghobadi G, Shakiba B. Attenuation of hepatic fibrosis throughcaptopril and enalapril in the livers of bile duct ligated rats. BiomedPharmacother 2008; 62: 312-6
21. Jin H, Yamamoto N, Uchida K, Terai S, Sakaida I. Telmisartan preventshepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. BiochemBiophys Res Commun 2007; 364: 801-7
22. Kaji K, Yoshiji H, Kitade M, Ikenaka Y, Noguchi R, Shirai Y, et al.Combination treatment of angiotensin II type I receptor blockerand new oral iron chelator attenuates progression of nonalcoholicsteatohepatitis in rats. Am J Physiol Gastrointest Liver Physiol 2011;300: G1094-104
23. Sukumaran V, Veeraveedu PT, Gurusamy N, Yamaguchi K,Lakshmanan AP, Ma M, et al. Cardioprotective effects of telmisartanagainst heart failure in rats induced by experimental autoimmunemyocarditis through the modulation of angiotensin-convertingenzyme-2/angiotensin 1-7/mas receptor axis. Int J Biol Sci 2011; 7:1077-92
24. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD. Effectof ACE2 and angiotensin-(1-7) in a mouse model of early chronickidney disease. Am J Physiol Renal Physiol 2010; 298: F1523-32
25. Conner KR, Forbes ME, Lee WH, Lee YW, Riddle DR. AT1 receptorantagonism does not influence early radiation-induced changes inmicroglial activation or neurogenesis in the normal rat brain. RadiatRes 2011; 176: 71-83
26. Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, et al.Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) andangiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol2007; 47: 387-95.